Using biomarkers to allocate patients in a response-adaptive clinical trial

DOI10.1080/03610918.2021.2004420OpenAlexW3215444642MaRDI QIDQ6204955FDOQ6204955

Authors:

Publication date: 11 April 2024

Published in: Communications in Statistics. Simulation and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610918.2021.2004420

zbMATH Keywords

personalized medicinebiomarkerpatient benefitresponse adaptive clinical trial

Mathematics Subject Classification ID

Statistics (62-XX)

Cites Work

• Gaussian processes for machine learning.
• Modeling survival data: extending the Cox model
• Regression Trees for Censored Data
• Local asymptotics for polynomial spline regression
• Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges
• Introduction to linear regression analysis.
• A Bayesian adaptive design for clinical trials in rare diseases
• Response-adaptive randomization for multi-arm clinical trials using the forward looking Gittins index rule
• Covariate-adjusted response-adaptive randomization for multi-arm clinical trials using a modified forward looking Gittins index rule
• Response-adaptive randomization in clinical trials: from myths to practical considerations

This page was built for publication: Using biomarkers to allocate patients in a response-adaptive clinical trial

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6204955)